ITGDF.US Integral Diagnostics Limited

Healthcare Biotechnology USA Stocks
2.61 USD
Close of Nov 14, 2026
0.9458 3.05
Market cap
USD 976M
P/E
65.3x
P/B
2.06x
ROE
3.2%
Dividend yield
2.47%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is ITGDF.US undervalued?

Graham number
Price2.61
Graham value1.07
Premium144.5%

ITGDF.US trades 144.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Integral Diagnostics Limited fundamental analysis

No fundamental analysis for Integral Diagnostics Limited yet.

Integral Diagnostics Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Integral Diagnostics Limited

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquar…

Full company profile